2009
DOI: 10.1111/j.1365-2036.2009.04171.x
|View full text |Cite
|
Sign up to set email alerts
|

Review article: anti‐fibrotic agents for the treatment of Crohn’s disease – lessons learnt from other diseases

Abstract: SUMMARY BackgroundThe current therapies for Crohn's disease (CD) are mainly focused on blockade of inflammation. Fibrosis remains one of the major complications of CD often leading to surgery, affecting patients' quality-of-life.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
28
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 29 publications
(28 citation statements)
references
References 121 publications
(246 reference statements)
0
28
0
Order By: Relevance
“…TGFβ represents one of the key molecules involved in stricture formation, promoting the phenotypic change of fibroblasts into myofibroblasts through the activation of the small mother against decapentaplegic SMAD proteins (Szabo et al, 2010). Bowel wall thickening appears macroscopically in the late stage of inflammation, although experimental evidence suggests that the underlying mechanisms begin at the very early stage of inflammation (Rieder et al, 2012).…”
Section: Inflammatory Bowel Disease Models In Intestinal Fibrosis Resmentioning
confidence: 99%
See 1 more Smart Citation
“…TGFβ represents one of the key molecules involved in stricture formation, promoting the phenotypic change of fibroblasts into myofibroblasts through the activation of the small mother against decapentaplegic SMAD proteins (Szabo et al, 2010). Bowel wall thickening appears macroscopically in the late stage of inflammation, although experimental evidence suggests that the underlying mechanisms begin at the very early stage of inflammation (Rieder et al, 2012).…”
Section: Inflammatory Bowel Disease Models In Intestinal Fibrosis Resmentioning
confidence: 99%
“…Bowel wall thickening appears macroscopically in the late stage of inflammation, although experimental evidence suggests that the underlying mechanisms begin at the very early stage of inflammation (Rieder et al, 2012). However, transforming growth factor β (TGFβ) targeting still represents a challenging task as it also exerts anti-inflammatory activity and mediates several cellular communication pathways (Szabo et al, 2010).…”
Section: Inflammatory Bowel Disease Models In Intestinal Fibrosis Resmentioning
confidence: 99%
“…In this instance, BMP-7 peptide binds to the extracellular 34 However, BMP-7 growth factor does not prevent 35 Bleomycin-induced adult human/mouse lung and skin specific fibrosis. The mechanism of BMP-7 opposing TGF-b1-mediated collagen induction in mouse pulmonary myofibroblasts was known to be mediated through Id2 protein 36 and other regulatory proteins in complex signaling pathways that are beyond the scope of this study.…”
Section: Discussionmentioning
confidence: 99%
“…This is important as complete knockdown of TGF-b1 can have deleterious effects on normal cellular functions. 34 The expression of Phospho-Smad 1/5/8 (Supplementary Fig. 2A) indicates that BMP-7 signaling is activated intracellularly, accumulating primarily in the cytosol.…”
Section: Discussionmentioning
confidence: 99%
“…Another review in this series addresses the promise of targeting myofibroblasts for stem cell therapy. All these approaches are being attempted in the management of liver fibrosis (discussed in another chapter of this series) or fibrosis associated with other chronic inflammatory disorders (36,51,56) and should be applied to the intestine. Finally, we need to take into account not only how, but also when to intervene in the evolving profibrogenic process.…”
Section: Clinical and Therapeutic Considerationsmentioning
confidence: 98%